Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to assess the safety of autologous fat grafting for women who have had operable primary breast cancer. The safety of autologous fat grafting can be divided into oncological safety and operation-related safety. Oncological safety will be evaluated mainly by local breast cancer recurrence rate. The operation-related safety will be measured mainly by post-operative morbidity. Our secondary objective is the efficacy of autologous fat grafting. The efficacy of autologous fat grafting will be measured mainly by quality of life questionnaires and cost-utility analysis. Fees for fat grafting will be accumulated if more than one grafting is needed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
